A carregar...

A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice

Apolipoprotein A-I (apoA-I) mimetic peptides are currently being developed as possible new agents for the treatment of cardiovascular disease based on their ability to promote cholesterol efflux and their other beneficial antiatherogenic properties. Many of these peptides, however, have been reporte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharmacol Exp Ther
Main Authors: Amar, Marcelo J. A., Sakurai, Toshihiro, Sakurai-Ikuta, Akiko, Sviridov, Denis, Freeman, Lita, Ahsan, Lusana, Remaley, Alan T.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293430/
https://ncbi.nlm.nih.gov/pubmed/25395590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.220418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!